Dow Jones

39,112.16

-0.76%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Sonus Pharmaceuticals (MM) (SNUS)
Sonus Pharmaceuticals (MM) (SNUS) Noticias

SNUS

Sonus (SNUS)

Sonus Pharmaceuticals (MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SNUS

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
21/08/2008	08:42	PR Newswire (US)	Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on	NASDAQ:SNUS
07/08/2008	15:41	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Current report filing (8-K)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
05/08/2008	16:02	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Quarterly Report (10-Q)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
21/07/2008	05:01	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
17/07/2008	14:10	PR Newswire (US)	Sonus Pharmaceuticals Receives Favorable NASDAQ Decision	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
03/07/2008	15:21	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
30/05/2008	10:37	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
30/05/2008	05:30	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Amended Securities Registration (section 12(g)) (8-A12G/A)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
28/05/2008	06:35	PR Newswire (US)	Sonus Pharmaceuticals and OncoGenex Technologies to Merge	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
29/04/2008	15:36	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Amended Annual Report (10-K/A)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
20/03/2008	16:57	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
14/03/2008	16:02	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Annual Report (10-K)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
13/02/2008	08:43	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Statement of Ownership (SC 13G)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
24/09/2007	12:41	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc (Other) (8-K)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
03/08/2007	10:00	Business Wire	Sonus Pharmaceuticals Highlights Corporate Progress and Reports Second Quarter Financial Results	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
19/07/2007	16:30	Business Wire	Sonus Pharmaceuticals to Release Second Quarter Financial Results and Hold Quarterly Conference Call on August 3	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
13/06/2007	07:30	Business Wire	Sonus Pharmaceuticals Awarded Patent for TOCOSOL(R) Camptothecin, the Company's Second Oncology Product Candidate	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
04/06/2007	15:30	Business Wire	Sonus Pharmaceuticals to Participate in Upcoming Investor Conferences	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
09/05/2007	15:15	Business Wire	Sonus Pharmaceuticals Highlights Progress and Reports First Quarter Financial Results	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
07/05/2007	18:39	Business Wire	Sonus Pharmaceuticals to Present at Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
03/05/2007	18:04	Business Wire	Sonus Pharmaceuticals to Release First Quarter Financial Results and Hold Conference Call on May 9	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
19/03/2007	17:39	Business Wire	Sonus Pharmaceuticals to Present at WBBA Invest Northwest(TM)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
14/03/2007	15:15	Business Wire	Sonus Pharmaceuticals Reviews Key Achievements in 2006 and Reports Fourth Quarter and Full Year Financial Results	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
07/03/2007	17:20	Business Wire	Sonus Pharmaceuticals to Release Fourth Quarter and Full Year 2006 Financial Results and Hold Year-end Conference Call on March	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
07/12/2006	16:30	Business Wire	Sonus Pharmaceuticals to Participate in RBC Capital Markets Healthcare Conference, December 13	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
21/11/2006	16:30	Business Wire	Sonus Pharmaceuticals to Present at Lazard Capital Markets Third Annual Life Sciences Conference, November 29	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
16/11/2006	07:30	Business Wire	Sonus Pharmaceuticals Announces Completion of Patient Enrollment in Phase 3 Pivotal Trial of TOCOSOL(R) Paclitaxel in Metastatic	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
08/11/2006	15:07	Business Wire	Sonus Pharmaceuticals Updates Corporate Progress and Reports Third Quarter Financial Results	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
31/10/2006	15:30	Business Wire	Sonus Pharmaceuticals to Release Third Quarter Financial Results and Hold Quarterly Conference Call November 8	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
28/09/2006	07:30	Business Wire	Sonus Pharmaceuticals Initiates Phase 1 Clinical Trial for Company's Second Anti-cancer Drug, TOCOSOL(R) Camptothecin	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)